Quest Diagnostics Incorporated
DGX
$190.18
$0.370.20%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.02B | 992.00M | 969.00M | 950.00M | 897.00M |
| Total Depreciation and Amortization | 577.00M | 570.00M | 560.00M | 543.00M | 517.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 319.00M | 274.00M | 337.00M | 229.00M | 185.00M |
| Change in Net Operating Assets | -70.00M | 50.00M | 19.00M | -44.00M | -105.00M |
| Cash from Operations | 1.85B | 1.89B | 1.89B | 1.68B | 1.49B |
| Capital Expenditure | -524.00M | -527.00M | -492.00M | -454.00M | -438.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -139.00M | -101.00M | -434.00M | -1.93B | -2.02B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.00M | -3.00M | -16.00M | 13.00M | 10.00M |
| Cash from Investing | -668.00M | -631.00M | -942.00M | -2.37B | -2.45B |
| Total Debt Issued | 195.00M | 410.00M | 410.00M | 2.25B | 2.06B |
| Total Debt Repaid | -413.00M | -1.01B | -1.01B | -1.00B | -903.00M |
| Issuance of Common Stock | 115.00M | 79.00M | 82.00M | 87.00M | 90.00M |
| Repurchase of Common Stock | -490.00M | -495.00M | -345.00M | -194.00M | -194.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -357.00M | -353.00M | -347.00M | -342.00M | -336.00M |
| Other Financing Activities | -29.00M | -17.00M | -59.00M | -48.00M | -42.00M |
| Cash from Financing | -979.00M | -1.39B | -1.27B | 746.00M | 676.00M |
| Foreign Exchange rate Adjustments | 2.00M | 4.00M | -4.00M | -2.00M | -6.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 205.00M | -129.00M | -332.00M | 48.00M | -286.00M |